anti-BTLA monoclonal antibody h22B3 in complex with BTLA
External Resource: Annotation
| Chains | Type | Family Name | Domain Identifier | Family Identifier | Provenance Source (Version) |
| C | SCOP2B Superfamily | Immunoglobulin (Ig) domain-like | 8054539 | 3000071 | SCOP2B (2022-06-29) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| | Light Chain | IGKV3 | Kappa | b- and t-lymphocyte attenuator | SAbDab (2025-12-05) |
| | Heavy Chain | IGHV1 | - | b- and t-lymphocyte attenuator | SAbDab (2025-12-05) |
| Chain | Name | Target | Provenance Source |
|---|
| Venanprubart | BTLA/CD272 | Therapeutic SAbDab (2025-12-05) |
| Venanprubart | BTLA/CD272 | Therapeutic SAbDab (2025-12-05) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| B- and T-lymphocyte attenuator | | | |
| h22B3 Fab light chain | - | - | - |
| h22B3 Fab heavy chain | - | - | - |
| Chains | Drug Target   | Associated Disease |
|---|
| Pharos:  Q7Z6A9 | |
Protein Modification Annotation
| Modified Residue(s) |
|---|
| Chain | Residue(s) | Description |
|---|
| | PCA | Parent Component: GLN
RESID:  AA0031
PSI-MOD :  2-pyrrolidone-5-carboxylic acid (Gln) MOD:00040 , 2-pyrrolidone-5-carboxylic acid (Glu) MOD:00420 |